These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35574020)

  • 21. Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity.
    Loid P; Mustila T; Mäkitie RE; Viljakainen H; Kämpe A; Tossavainen P; Lipsanen-Nyman M; Pekkinen M; Mäkitie O
    Front Endocrinol (Lausanne); 2020; 11():81. PubMed ID: 32153512
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding the Genetics of Early-Onset Obesity in a Cohort of Children From Qatar.
    Mohammed I; Haris B; Al-Barazenji T; Vasudeva D; Tomei S; Al Azwani I; Dauleh H; Shehzad S; Chirayath S; Mohamadsalih G; Petrovski G; Khalifa A; Love DR; Al-Shafai M; Hussain K
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3201-3213. PubMed ID: 37329217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system.
    Suazo J; Hodgson MI; Obregón AM; Valladares M; Weisstaub G; Amador P; Santos JL
    J Pediatr Endocrinol Metab; 2013; 26(11-12):1131-9. PubMed ID: 23817596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular characterisation of children with monogenic obesity: a case series.
    George A; Navi S; Nanda P; Daniel R; Anand K; Banerjee S; Panigrahi I; Dayal D
    Pediatr Endocrinol Diabetes Metab; 2024; 30(2):104-109. PubMed ID: 39026488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity.
    Potoczna N; Branson R; Kral JG; Piec G; Steffen R; Ricklin T; Hoehe MR; Lentes KU; Horber FF
    J Gastrointest Surg; 2004 Dec; 8(8):971-81; discussion 981-2. PubMed ID: 15585384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N221D variant in
    Guijo B; Argente J; Martos-Moreno GÁ
    J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1140-1145. PubMed ID: 37877373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.
    Hinney A; Körner A; Fischer-Posovszky P
    Nat Rev Endocrinol; 2022 Oct; 18(10):623-637. PubMed ID: 35902734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in Genes Involved in the Leptin-Melanocortin Pathway are Associated with Obesity-Related Cardiometabolic Alterations in a Southern Chilean Population.
    Manriquez V; Aviles J; Salazar L; Saavedra N; Seron P; Lanas F; Fajardo CM; Hirata MH; Hirata RDC; Cerda A
    Mol Diagn Ther; 2018 Feb; 22(1):101-113. PubMed ID: 28975585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of LEP, MRAP2 and POMC genes as potential causes of severe obesity in Brazilian patients.
    da Fonseca ACP; Abreu GM; Zembrzuski VM; Campos Junior M; Carneiro JRI; Nogueira Neto JF; Magno FCCM; Rosado EL; Bozza PT; de Cabello GMK; Cabello PH
    Eat Weight Disord; 2021 Jun; 26(5):1399-1408. PubMed ID: 32578125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Melanocortin-4 Receptor Agonist Induces Skin and Hair Pigmentation in Patients with Monogenic Mutations in the Leptin-Melanocortin Pathway.
    Kanti V; Puder L; Jahnke I; Krabusch PM; Kottner J; Vogt A; Richter C; Andruck A; Lechner L; Poitou C; Krude H; Gottesdiener K; Clément K; Farooqi IS; Wiegand S; Kühnen P; Blume-Peytavi U
    Skin Pharmacol Physiol; 2021; 34(6):307-316. PubMed ID: 34058738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Loss of Function Melanocortin-4-Receptor Mutation (MC4R-F313Sfs*29) in Morbid Obesity.
    Trevellin E; Granzotto M; Host C; Grisan F; De Stefani D; Grinzato A; Lefkimmiatis K; Pagano C; Rizzuto R; Vettor R
    J Clin Endocrinol Metab; 2021 Mar; 106(3):736-749. PubMed ID: 33247923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional Characterization of Novel
    Mohammed I; Selvaraj S; Ahmed WS; Al-Barazenji T; Hammad AS; Dauleh H; Saraiva LR; Al-Shafai M; Hussain K
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel leptin receptor (LEPR) variant and proof of functional relevance directing treatment decisions in patients with morbid obesity.
    Voigtmann F; Wolf P; Landgraf K; Stein R; Kratzsch J; Schmitz S; Abou Jamra R; Blüher M; Meiler J; Beck-Sickinger AG; Kiess W; Körner A
    Metabolism; 2021 Mar; 116():154438. PubMed ID: 33221380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of leptin-melanocortin system and human weight regulation: lessons from experiments of nature.
    Lee YS
    Ann Acad Med Singap; 2009 Jan; 38(1):34-11. PubMed ID: 19221669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics of Severe Obesity.
    Fairbrother U; Kidd E; Malagamuwa T; Walley A
    Curr Diab Rep; 2018 Aug; 18(10):85. PubMed ID: 30121879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
    Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P;
    Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Targeted Next Generation Sequencing Panel for Non-syndromic Early Onset Severe Obesity and Identification of Novel Likely -Pathogenic Variants in the MC4R and LEP Genes.
    Khadilkar V; Gogate N; Gangodkar P; Ranade S; Lohiya N; Ragte T; Patil K; Pilankar A; Anand S; Bapat A; Agarwal M; Kaushik K; Lote-Oke R; Khadilkar A; Phadke N
    Indian J Pediatr; 2020 Feb; 87(2):105-110. PubMed ID: 31925720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the leptin-melanocortin signalling pathway in the control of food intake.
    Beckers S; Zegers D; Van Gaal LF; Van Hul W
    Crit Rev Eukaryot Gene Expr; 2009; 19(4):267-87. PubMed ID: 19817705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations between obesity candidate gene polymorphisms (fat mass and obesity-associated (FTO), melanocortin-4 receptor (MC4R), leptin (LEP) and leptin receptor (LEPR)) and dietary intake in pregnant women.
    Martins MC; Trujillo J; Freitas-Vilela AA; Farias DR; Rosado EL; Struchiner CJ; Kac G
    Br J Nutr; 2018 Aug; 120(4):454-463. PubMed ID: 29893663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel variants in the MC4R and LEPR genes among severely obese children from the Iberian population.
    Albuquerque D; Estévez MN; Víbora PB; Giralt PS; Balsera AM; Cortés PG; López MJ; Luego LM; Gervasini G; Hernández SB; Arroyo-Díez J; Vacas MA; Nóbrega C; Manco L; Rodríguez-López R
    Ann Hum Genet; 2014 May; 78(3):195-207. PubMed ID: 24611737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.